Dinesh ParmarAssociate Director Regulatory Affairs at PolyPeptide GroupSpeaker
Agenda Sessions
Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase
, 11:30amView Session